203 related articles for article (PubMed ID: 35948080)
1. Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multicancer Early Detection Tests to Assess the Clinical Significance of Cancers.
Bredno J; Venn O; Chen X; Freese P; Ofman JJ
Am J Pathol; 2022 Oct; 192(10):1368-1378. PubMed ID: 35948080
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell-free DNA approaches for multi-cancer early detection.
Jamshidi A; Liu MC; Klein EA; Venn O; Hubbell E; Beausang JF; Gross S; Melton C; Fields AP; Liu Q; Zhang N; Fung ET; Kurtzman KN; Amini H; Betts C; Civello D; Freese P; Calef R; Davydov K; Fayzullina S; Hou C; Jiang R; Jung B; Tang S; Demas V; Newman J; Sakarya O; Scott E; Shenoy A; Shojaee S; Steffen KK; Nicula V; Chien TC; Bagaria S; Hunkapiller N; Desai M; Dong Z; Richards DA; Yeatman TJ; Cohn AL; Thiel DD; Berry DA; Tummala MK; McIntyre K; Sekeres MA; Bryce A; Aravanis AM; Seiden MV; Swanton C
Cancer Cell; 2022 Dec; 40(12):1537-1549.e12. PubMed ID: 36400018
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Klein EA; Richards D; Cohn A; Tummala M; Lapham R; Cosgrove D; Chung G; Clement J; Gao J; Hunkapiller N; Jamshidi A; Kurtzman KN; Seiden MV; Swanton C; Liu MC
Ann Oncol; 2021 Sep; 32(9):1167-1177. PubMed ID: 34176681
[TBL] [Abstract][Full Text] [Related]
5. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
6. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
Croessmann S; Park BH
Clin Adv Hematol Oncol; 2021 Mar; 19(3):155-161. PubMed ID: 33739964
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA-based multi-cancer early detection.
Zhang K; Fu R; Liu R; Su Z
Trends Cancer; 2024 Feb; 10(2):161-174. PubMed ID: 37709615
[TBL] [Abstract][Full Text] [Related]
9. Multicancer Early Detection Tests: An Overview of Early Results From Prospective Clinical Studies and Opportunities for Oncologists.
Post C; Braun TP; Etzioni R; Nabavizadeh N
JCO Oncol Pract; 2023 Dec; 19(12):1111-1115. PubMed ID: 37851937
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.
Tie J; Cohen JD; Lo SN; Wang Y; Li L; Christie M; Lee M; Wong R; Kosmider S; Skinner I; Wong HL; Lee B; Burge ME; Yip D; Karapetis CS; Price TJ; Tebbutt NC; Haydon AM; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Popoli M; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
Int J Cancer; 2021 Feb; 148(4):1014-1026. PubMed ID: 32984952
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy.
Trosman JR; Weldon CB; Kurian AW; Pasquinelli MM; Kircher SM; Martin N; Douglas MP; Phillips KA
Health Aff Sch; 2023 Jul; 1(1):qxad005. PubMed ID: 38756840
[TBL] [Abstract][Full Text] [Related]
12. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free tumor DNA analysis in pediatric cancers.
Andersson D; Fagman H; Dalin MG; Ståhlberg A
Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
[TBL] [Abstract][Full Text] [Related]
14. Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling.
Lange JM; Gogebakan KC; Gulati R; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):830-837. PubMed ID: 38506751
[TBL] [Abstract][Full Text] [Related]
15. Multicancer Early Detection: Learning From the Past to Meet the Future.
Etzioni R; Gulati R; Weiss NS
J Natl Cancer Inst; 2022 Mar; 114(3):349-352. PubMed ID: 34450655
[TBL] [Abstract][Full Text] [Related]
16. Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?
Lenaerts L; Tuveri S; Jatsenko T; Amant F; Vermeesch JR
Acta Clin Belg; 2020 Feb; 75(1):9-18. PubMed ID: 31578135
[No Abstract] [Full Text] [Related]
17. Diagnostic potential of circulating cell-free nuclear and mitochondrial DNA for several cancer types and nonmalignant diseases: A study on suspected cancer patients.
Sundquist K; Sundquist J; Hedelius A; Memon AA
Mol Carcinog; 2020 Dec; 59(12):1362-1370. PubMed ID: 33051887
[TBL] [Abstract][Full Text] [Related]
18. Mutant
Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA as an early cancer detection tool.
Campos-Carrillo A; Weitzel JN; Sahoo P; Rockne R; Mokhnatkin JV; Murtaza M; Gray SW; Goetz L; Goel A; Schork N; Slavin TP
Pharmacol Ther; 2020 Mar; 207():107458. PubMed ID: 31863816
[TBL] [Abstract][Full Text] [Related]
20. The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm.
Klein EA; Beer TM; Seiden M
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
